Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michiel T van Diepen

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Developmental Neuroscience|December 14, 2007
Function of PTEN during the formation and maintenance of neuronal circuits in the brainMichiel T van Diepen, Britta J Eickholt
Advances in Enzyme Regulation|November 10, 2009
Regulation of PTEN in neurons by myosin-based transport mechanismsPatricia Kreis, Michiel T van Diepen, Britta J Eickholt
Nature Cell Biology|September 22, 2009
MyosinV controls PTEN function and neuronal cell sizeMichiel T van Diepen, Maddy Parsons, C Peter Downes, et al.
Frontiers in Bioengineering and Biotechnology|April 25, 2020
Characterization and Immunogenicity of HIV Envelope gp140 Zera<sup>®</sup> Tagged AntigensPhindile Ximba, Rosamund Chapman, Ann E Meyers, et al.
Vaccine|December 21, 2020
Modifications to the HIV-1 SAAVI MVA-C vaccine improve in vitro expression and in vivo immunogenicityNicola Douglass, Michiel T van Diepen, Rosamund Chapman, et al.
Plos One|December 18, 2018
The adjuvant AlhydroGel elicits higher antibody titres than AddaVax when combined with HIV-1 subtype C gp140 from CAP256Michiel T van Diepen, Rosamund Chapman, Penny L Moore, et al.
Journal of Virology|February 15, 2019
Prime-Boost Immunizations with DNA, Modified Vaccinia Virus Ankara, and Protein-Based Vaccines Elicit Robust HIV-1 Tier 2 Neutralizing Antibodies against the CAP256 Superinfecting VirusMichiel T van Diepen, Rosamund Chapman, Nicola Douglass, et al.
Nanotechnology|July 26, 2022
Development of a synthetic nanoparticle vaccine presenting the HIV-1 envelope glycoproteinPhindile Ximba, Rosamund Chapman, Ann Meyers, et al.
Assay and Drug Development Technologies|June 7, 2014
The development of automated patch clamp assays for canonical transient receptor potential channels TRPC3, 6, and 7Mark McPate, Gurdip Bhalay, Martin Beckett, et al.
Frontiers in Plant Science|November 19, 2019
Production and Immunogenicity of Soluble Plant-Produced HIV-1 Subtype C Envelope gp140 ImmunogensEmmanuel Margolin, Rosamund Chapman, Ann E Meyers, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Developmental Neuroscience|December 14, 2007
Function of PTEN during the formation and maintenance of neuronal circuits in the brainMichiel T van Diepen, Britta J Eickholt
Advances in Enzyme Regulation|November 10, 2009
Regulation of PTEN in neurons by myosin-based transport mechanismsPatricia Kreis, Michiel T van Diepen, Britta J Eickholt
Nature Cell Biology|September 22, 2009
MyosinV controls PTEN function and neuronal cell sizeMichiel T van Diepen, Maddy Parsons, C Peter Downes, et al.
Frontiers in Bioengineering and Biotechnology|April 25, 2020
Characterization and Immunogenicity of HIV Envelope gp140 Zera<sup>®</sup> Tagged AntigensPhindile Ximba, Rosamund Chapman, Ann E Meyers, et al.
Vaccine|December 21, 2020
Modifications to the HIV-1 SAAVI MVA-C vaccine improve in vitro expression and in vivo immunogenicityNicola Douglass, Michiel T van Diepen, Rosamund Chapman, et al.
Plos One|December 18, 2018
The adjuvant AlhydroGel elicits higher antibody titres than AddaVax when combined with HIV-1 subtype C gp140 from CAP256Michiel T van Diepen, Rosamund Chapman, Penny L Moore, et al.
Journal of Virology|February 15, 2019
Prime-Boost Immunizations with DNA, Modified Vaccinia Virus Ankara, and Protein-Based Vaccines Elicit Robust HIV-1 Tier 2 Neutralizing Antibodies against the CAP256 Superinfecting VirusMichiel T van Diepen, Rosamund Chapman, Nicola Douglass, et al.
Nanotechnology|July 26, 2022
Development of a synthetic nanoparticle vaccine presenting the HIV-1 envelope glycoproteinPhindile Ximba, Rosamund Chapman, Ann Meyers, et al.
Assay and Drug Development Technologies|June 7, 2014
The development of automated patch clamp assays for canonical transient receptor potential channels TRPC3, 6, and 7Mark McPate, Gurdip Bhalay, Martin Beckett, et al.
Frontiers in Plant Science|November 19, 2019
Production and Immunogenicity of Soluble Plant-Produced HIV-1 Subtype C Envelope gp140 ImmunogensEmmanuel Margolin, Rosamund Chapman, Ann E Meyers, et al.
Pageof 2